Lawrence D. Phillips

London School of Economics and Political Science — United Kingdom

Economics, Econometrics and Finance · Social Sciences

37h-index10.2kcitations144works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(23), Complex Systems and Decision Making(23), Decision-Making and Behavioral Economics(14), Bayesian Modeling and Causal Inference(13), Opioid Use Disorder Treatment(9)

Publications144 total

US drug policy does not align with experts’ rankings of drug harms: a multi-criteria decision analysis
Harm Reduction Journal·2025Open Access
Decision Analysis for Practitioners
Decision Analysis·2025· 1 cited
Comment on “Whose Judgement? Reflections on Elicitation in Bayesian Analysis”
Decision Analysis·2024· 1 cited
What interventions should we implement in England's mental health services? The mental health implementation network (MHIN) mixed-methods approach to rapid prioritisation
Frontiers in Health Services·2023· 3 citedOpen Access
Bayesian analysis of real‐world data as evidence for drug approval: Remembering Sir Michael Rawlins
British Journal of Clinical Pharmacology·2023· 10 citedOpen Access
The value of real world evidence: The case of medical cannabis
Frontiers in Psychiatry·2022· 38 citedOpen Access
Multi-Criteria Decision Analysis for Benefit-Risk Analysis by National Regulatory Authorities
Frontiers in Medicine·2022· 25 citedOpen Access
A comparative study of the harms of nitrous oxide and poppers using the MCDA approach
Drug Science Policy and Law·2022· 5 citedOpen Access
Medical cannabis for severe treatment resistant epilepsy in children: a case-series of 10 patients
BMJ Paediatrics Open·2021· 16 citedOpen Access
A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products
Cannabis and Cannabinoid Research·2021· 45 citedOpen Access
A multi criteria decision analysis (MCDA) for evaluating and appraising government policy responses to non medical heroin use
International Journal of Drug Policy·2021· 10 cited
Corrigendum re “Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex” [Eur Urol Focus 2020;6:522–30]
European Urology Focus·2021· 4 citedOpen Access
<p>Multi-Criteria Decision Analysis to Develop an Efficacy-Safety Profile of Parenteral Analgesics Used in the Treatment of Postoperative Pain</p>
Journal of Pain Research·2020· 9 citedOpen Access
So near yet so far: why won’t the UK prescribe medical cannabis?
BMJ Open·2020· 50 citedOpen Access
ICER Value Framework 2020 Update: Recommendations on the Aggregation of Benefits and Contextual Considerations
Value in Health·2020· 18 cited
Advancing structured decision‐making in drug regulation at the FDA and EMA
British Journal of Clinical Pharmacology·2020· 27 citedOpen Access
Medical cannabis in the UK: From principle to practice
Journal of Psychopharmacology·2020· 46 citedOpen Access
Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex
European Urology Focus·2019· 37 cited
Quantifying Preferences in Drug Benefit‐Risk Decisions
Clinical Pharmacology & Therapeutics·2019· 24 citedOpen Access
Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis
Clinical Therapeutics·2019· 23 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

David Nutt(5), Anne Katrin Schlag(5), Valerie H. Curran(4), David Nutt(4), Sarah Lichtenstein(3), Baruch Fischhoff(3), Ward Edwards(3), George Wright(3), Shahrul Mt‐Isa(3), Christine E. Hallgreen(3), Kimberley Hockley(3), Alain Micaleff(3), Deborah Ashby(3), David J.K. Balfour(2), Martin Dockrell(2), Jonathan Foulds(2), Karl Fagerström(2), Kgosi Letlape(2), Riccardo Polosa(2), J. Michael Ramsey(2)